Company Profile
Area of Focus:
Therapeutic
Stage:
Preclinical
Contact Info:
Michael J. Reilly, CEO
Email:
info@westernstatesbiopharm.com
Web:
http://www.westernstatesbiopharm.com
Western States Biopharmaceuticals, Inc. (WSBI) is a privately held biopharmaceutical company developing novel therapies that selectively modulate adaptive immunity to treat inflammatory diseases. Currently valued over $16B, the global autoimmune market still does not have therapies that adequately address either the efficacy or safety needs of the target populations. The company founders have deep experience in discovering, developing, and commercializing therapies in autoimmune disease and plan to utilize both small molecule and biologic approaches. Western States has several exploratory programs based on technology from the University of Colorado Denver, Anschutz Medical Center.